Income statement, balance sheet and cash flow statement for the last 2 fiscal years, taken from the XBRL data Semilux International Ltd. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2023
FY2024
Revenue
1.07
3.67
Cost of revenue
1.57
4.54
Gross profit
-0.5
-0.87
Research and development
0.79
1.07
General and administrative
0.8
2.47
Operating expenses
1.96
4.52
Operating income
-2.45
-5.39
Interest expense
0.1
0.1
Interest income
0.48
0.27
Other non-operating income
0.43
0.74
Pre-tax income
-2.03
-4.66
Income tax
0.03
-0.02
Net income to minority interests
-0.43
-0.96
Net income
-1.63
-3.68
EBITDA
-1.99
-4.99
EPS, basic
-0.21
-0.10
EPS, diluted
-0.21
-0.10
Shares, basic (weighted)
30.2
37.6
Shares, diluted (weighted)
30.2
37.6
Balance sheet
FY2023
FY2024
Cash and equivalents
6.61
3.59
Receivables
0.18
0.2
Inventory
1.56
0.49
Other current assets
0.23
0.58
Total current assets
11.6
7.36
Property, plant and equipment
1.57
1.32
Lease right-of-use assets
0.26
0.78
Other non-current assets
0.23
0.13
Total assets
14.7
9.61
Accounts payable
0
Short-term debt
2.94
2.75
Total current liabilities
4.01
6.87
Long-term debt
1.41
0.94
Lease liabilities
0.41
Total liabilities
5.42
8.22
Total debt
1.41
0.94
Paid-in capital
8.5
5.36
Retained earnings
-1.53
-5.11
Other comprehensive income
-0.03
Shareholders' equity
7.33
0.57
Minority interests
1.91
0.82
Total equity
9.24
1.39
Total liabilities and equity
14.7
9.61
Shares outstanding
30.2
37.4
Cash flow statement
FY2023
FY2024
Net income
-2.06
-4.63
Depreciation and amortization
0.47
0.4
Deferred income tax
0.03
-0.02
Change in receivables
0.04
-0.03
Change in inventory
-0.36
0.37
Change in payables
-0.05
-0
Cash from operations
-1.24
0.07
Capital expenditures
-0.77
-0.64
Cash from investing
-0.77
-1.11
Debt repaid
-0.6
-0.2
Cash from financing
-2.21
-1.82
Exchange rate effect
-0.03
Net change in cash
-4.23
-2.89
Free cash flow
-2.02
-0.58
Income taxes paid
0.1
0.09
Key metrics
Worked out from the statements above. Latest values use fiscal 2024. Valuation uses the share price of $0.00 on November 9, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
-23.7%
Gross profit / revenue.
Operating margin
-147.0%
Operating income / revenue.
EBITDA margin
-136.1%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-127.0%
Pre-tax income / revenue.
Net margin
-100.3%
Net income / revenue.
FCF margin
-15.8%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
1.8%
Cash from operations / revenue.
Return on equity (ROE)
-93.1%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-30.3%
Net income / average total assets.
Return on invested capital (ROIC)
-18,126.0%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
29.1%
Research and development expense / revenue.
Capex / revenue
17.6%
Capital expenditures / revenue.
D&A / revenue
10.9%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
241.8%
Revenue vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-92.2%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-34.4%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
24.7%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.07x
Current assets / current liabilities.
Quick ratio
0.55x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.52x
(Cash + short-term investments) / current liabilities.
Debt / equity
1.65x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
9.8%
Total debt / total assets.
Liabilities / assets
85.5%
Total liabilities / total assets.
Net debt
-$2.7M
Total debt - cash - short-term investments. Negative means more cash than debt.
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.10
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.10
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.10
Revenue / diluted weighted shares.
FCF per share
-$0.02
Free cash flow / diluted weighted shares.
Operating cash flow per share
$0.00
Cash from operations / diluted weighted shares.
Book value per share
$0.02
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.01x
Market cap / revenue.
P/B
0.03x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.03x
Market cap / tangible book value, when positive.
P/OCF
0.28x
Market cap / cash from operations, when positive.
FCF yield
-3,075.0%
Free cash flow / market cap.
Earnings yield
-19,561.0%
Net income / market cap (the inverse of P/E).
What was Semilux International Ltd.'s revenue in fiscal 2024?
Semilux International Ltd. reported revenue of $3.7M for fiscal 2024, 241.8% higher than the year before.
Was Semilux International Ltd. profitable in fiscal 2024?
No. It reported a net loss of $3.7M.
How much free cash flow did Semilux International Ltd. generate in fiscal 2024?
Cash from operations of $66.0K minus capital expenditures of $644.0K left free cash flow of -$578.0K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.